Glaxo Drug Faces More Scrutiny A Senate report that revives concerns about a GlaxoSmithKline diabetes drug's link to heart attacks is putting pressure on the Food and Drug Administration to make changes to its drug-safety program. 02-22-2010 by bmasters2397 Tags drug, glaxo, more, scrutiny
